QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser



Status:Completed
Conditions:Breast Cancer, Cancer, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases, Oncology
Healthy:No
Age Range:18 - Any
Updated:2/9/2018
Start Date:February 2013
End Date:February 2018

Use our guide to learn which trials are right for you!

Quality of Life Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser

The purpose of this study is to see how the look of telangiectasias (small dilated blood
vessels) on radiated breast skin when altered by the pulsed dye laser affects a patient's
overall well being.

Patients will have a set of treatments with a pulsed dye laser. This is a laser that targets
red blood vessels and delivers heat causing the telangiectasias to become smaller and less
visible. The laser has been used safely to treat telangiectasias on the skin of patients who
received radiation for breast cancer.

Patients in the study will be asked to complete a questionnaire asking how they feel about
the telangiectasias, their radiated skin and its effect on their daily lives. The
questionnaire will be given at every visit. The improvement in the look of patients' radiated
skin will also be compared to answers to the questionnaire. We hope the study will improve
our understanding of how patients feel about the long term effects of radiation on their
skin.


Inclusion Criteria:

- Locally advanced breast cancer patients treated with surgery and adjuvant radiation

- Telangiectasias in the radiation field of the treated breast

- Patients 18 years or older

Exclusion Criteria:

- Non English speaking

- Current oral steroid use or receiving daily therapeutic anticoagulation (e.g.
Coumadin, Lovenox)

- Breast/s reconstructed with implant in the area of previous radiation

- Pregnancy or lactation

- Previous laser treatment of telangiectasias

- Presence of a sun tan in the area

- Fitzpatrick skin types V, VI
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Erica Lee, MD
Phone: 646-888-6015
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials